Schrodinger(SDGR) - 2023 Q2 - Earnings Call Presentation

Transforming Discovery of Therapeutics and Materials Cautionary Note and Disclaimer This presentation contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this presentation, including, without limitation, statements regarding the potential advantages of our computational platform, our strategic plans to accelerate th ...